Atossa Therapeutics
ATOS
#10757
Rank
ยฃ14.6 M
Marketcap
ยฃ1.46
Share price
-1.53%
Change (1 day)
143.80%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): -ยฃ3.05

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ3.10. In 2025 the company made an earnings per share (EPS) of -ยฃ3.06 a decrease over its 2024 EPS that were of -ยฃ2.31.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ3.05-0.44%
2025-ยฃ3.0632.89%
2024-ยฃ2.31-15.56%
2023-ยฃ2.7314.29%
2022-ยฃ2.3916.67%
2021-ยฃ2.05-90.86%
2020-ยฃ22.41-2.96%
2019-ยฃ23.09-63.09%
2018-ยฃ62.56-49.63%
2017-ยฃ124.21-57.87%
2016-ยฃ294.82-74.01%
2015-ยฃ1,134-9.18%
2014-ยฃ1,249-12.86%
2013-ยฃ1,43370.73%
2012-ยฃ839.4334.07%
2011-ยฃ626.11263.41%
2010-ยฃ172.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.07-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ7.72-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ9.30-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ0.19-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ0.16-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA